In patients naïve to chemotherapy treatment, CEA, number of metastatic sites, age, NLR, lactate dehydrogenase levels, and primary tumour location, have been shown to be important prognostic indicators [15–18]. This evidence concerns the gene CEACAM5 and neoplasm.